Compare BMEA & RENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMEA | RENT |
|---|---|---|
| Founded | 2017 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.1M | 101.1M |
| IPO Year | 2021 | 2021 |
| Metric | BMEA | RENT |
|---|---|---|
| Price | $1.27 | $3.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $9.83 | N/A |
| AVG Volume (30 Days) | ★ 566.6K | 45.8K |
| Earning Date | 05-12-2026 | 04-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 69.19 | ★ 110.16 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $329,800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.71 |
| 52 Week Low | $0.87 | $2.88 |
| 52 Week High | $2.99 | $10.13 |
| Indicator | BMEA | RENT |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 56.45 |
| Support Level | $1.21 | $3.32 |
| Resistance Level | $1.44 | $3.63 |
| Average True Range (ATR) | 0.06 | 0.26 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 58.14 | 72.68 |
Biomea Fusion Inc is a a clinical stage diabetes and obesity medicines company focused on the discovery and development of oral, small molecule drugs to treat and improve the lives of patients with diabetes, obesity, and other metabolic diseases. It operate as an organization centered on two of its core drug candidate development programs: (i) icovamenib, its clinical program's drug candidate, currently being developed as an orally bioavailable, and selective, covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib's potential in type 1 and type 2 diabetes, as well as its impact in obesity, and (ii) BMF-650, its investigational, next-generation oral glucagon-like peptide-1 GLP-1 receptor agonist in development for the treatment of obesity.
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe to, or buy designer apparel and accessories. The company gives customers access to its unlimited closet through its subscription offering (Subscription) or the ability to rent a-la-carte through its reserve offering (Reserve). The company also gives its subscribers and customers the ability to buy its products through its Resale offering. The Closet in the Cloud offers a wide assortment of items for every occasion, from evening wear and accessories to ready-to-wear, workwear, denim, casual, maternity, outerwear, blouses, knitwear, loungewear, jewelry, handbags, activewear, and ski wear.